Literature DB >> 19463714

Intraamygdaloid microinjection of acylated-ghrelin influences passive avoidance learning.

Krisztián Tóth1, Kristóf László, Edit Lukács, László Lénárd.   

Abstract

The brain-gut peptide acylated-ghrelin (A-Ghr) is a potent growth hormone (GH) secretagogue substance. A-Ghr is also known to influence on memory and learning processes. Its effect is mediated partly via GH secretagogue receptor (GHS-R) type 1a. The amygdaloid body (AMY) plays important role in memory and learning processes. Projections of ghrelinergic neurons were identified in the AMY, and previously we verified that A-Ghr infused into basolateral nucleus of the AMY (ABL) caused liquid food intake decrease. The aim of the present study was to examine the possible effects of A-Ghr in the ABL on learning. Male Wistar rats were examined in two-compartment passive avoidance paradigm. Animals were shocked with 0.4mA current and subsequently were microinjected bilaterally with 50 or 100 ng A-Ghr, 30 ng GHS-R antagonist d-Lys3-GHRP-6 (ANT), ANT+50 ng A-Ghr (dissolved in 0.15M sterile NaCl/0.4 microl) or vehicle into the ABL. Fifty nanogram A-Ghr significantly increased the latency time, the 100 ng and the ANT alone were ineffective. The effect of 50 ng A-Ghr was eliminated by the ANT pretreatment. Our results suggest that intraamygdaloid A-Ghr enhances learning processes and memory in aversive situations, and this effect can specifically be prevented by ANT pretreatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463714     DOI: 10.1016/j.bbr.2009.03.031

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

Review 1.  Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Rhonda D Kineman; Raúl M Luque; Justo P Castaño
Journal:  Peptides       Date:  2011-10-01       Impact factor: 3.750

Review 2.  Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits.

Authors:  Manoranjan S D'Souza
Journal:  Front Psychiatry       Date:  2019-07-24       Impact factor: 4.157

Review 3.  Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y.

Authors:  Lucas B Comeras; Herbert Herzog; Ramon O Tasan
Journal:  Ann N Y Acad Sci       Date:  2019-07-04       Impact factor: 5.691

Review 4.  Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury.

Authors:  Irina Stoyanova; David Lutz
Journal:  Front Cell Dev Biol       Date:  2021-03-25

5.  The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence.

Authors:  Mayte Alvarez-Crespo; Karolina P Skibicka; Imre Farkas; Csilla S Molnár; Emil Egecioglu; Erik Hrabovszky; Zsolt Liposits; Suzanne L Dickson
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

6.  NBM-T-L-BMX-OS01, Semisynthesized from Osthole, Is a Novel Inhibitor of Histone Deacetylase and Enhances Learning and Memory in Rats.

Authors:  Ying-Chen Yang; Chia-Nan Chen; Carol-Imei Wu; Wei-Jan Huang; Tsun-Yung Kuo; Ming-Chung Kuan; Tung-Hu Tsai; Jing-Shi Huang; Chung-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

7.  Ghrelin modulates lateral amygdala neuronal firing and blocks acquisition for conditioned taste aversion.

Authors:  Lige Song; Qianqian Zhu; Tianwei Liu; Ming Yu; Kewei Xiao; Qingnuan Kong; Renliang Zhao; Guo-Dong Li; Yu Zhou
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

8.  Ghrelin accelerates synapse formation and activity development in cultured cortical networks.

Authors:  Irina I Stoyanova; Joost le Feber
Journal:  BMC Neurosci       Date:  2014-04-17       Impact factor: 3.288

9.  Ghrelin is a possible new predictor associated with executive function in patients with type 2 diabetes mellitus.

Authors:  Siting Chen; Xuyang Zuo; Yuan Li; Tian Jiang; Nan Zhang; Fang Dai; Qiaoer Chen; Qiu Zhang
Journal:  J Diabetes Investig       Date:  2016-11-15       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.